Objective To discuss the efficacy,qualification rate and costs of pharmacotherapy for elderly patients with metabolism syndrome.Methods The investigation was based on a descriptive analysis related to medical files of 206 elderly in-patients (>60-year-old) with metabolism syndrome (MS) during 2008 to 2009.The diagnosis was confirmed by the standards of Chinese Diabetes Association.The agents used for each component of MS,therapeutic effect,costs,and qualification rate were recorded.Results The efficiency rates of the pharmacotherapy for diabetes,hypertension,hyperlipidemia,hyperuricemia and anticoagulation were 98.0%,70.9%,85.0%,42.6% and 83.3% respectively.The qualification rates of control of HbA1c,fasting glucose,postprandial glucose,blood pressure,triglyceride,HDL,and uricemia were 45.1%,70.0%,52.9%,79.1%,80.2% and 40.0% respectively.The more satisfaction rates of control of these indices were 85.0%,88.9%,93.7%,99.4%,95.6%,77.5% and 97.0% respectively.The daily costs of all the agents used for metabolism syndrome <30 yuan,30-60 yuan,and >60 yuan accounted for 50.0%,38.3% and 11.7% respectively.Conclusion In order to get satisfactory qualification rate,as well as ideal cost-effectiveness ratio,the medications should be chosen reasonably according to the characteristics of elderly patients with metabolism syndrome and the principles of comprehensive therapy.